We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen (SSAT033)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01190293
Recruitment Status : Completed
First Posted : August 27, 2010
Last Update Posted : April 12, 2012
Information provided by (Responsible Party):
St Stephens Aids Trust

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2012
  Study Completion Date : March 2012